Bridging the gap between biomarker testing and treatment in community oncology

McKesson's Precision Care Companion initiative enhances biomarker testing and targeted therapies in community oncology, improving patient outcomes and cost efficiency.

Authors

Publication Details

Journal
The American Journal of Managed Care
Published
2025-12-01
DOI
https://doi.org/10.37765/ajmc.2025.89877
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bridging the gap between biomarker testing and treatment in community oncology

Suzzette Arnal, Regina Murphy
The American Journal of Managed Care
HER2/EGFR in Cancer Research
article

Bridging the gap between biomarker testing and treatment in community oncology

Suzzette Arnal, Regina Murphy
article en

Abstract

McKesson's Precision Care Companion initiative enhances biomarker testing and targeted therapies in community oncology, improving patient outcomes and cost efficiency.

The American Journal of Managed CareVol. 31(Spec. No. 13)
Openalex Percentile: Top 28%
HER2/EGFR in Cancer Research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Bridging the gap between biomarker testing and treatment in community oncology — Suzzette Arnal, Regina Murphy · The American Journal of Managed Care (2025) | TGRS Research Map | TGRS